Startup entity
market-trends is the sole category represented across all 1 tracked stories. Ben Lamm is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 4 original sources each against 2.6 for the same window.
Last mentioned: Mar 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Ben Lamm is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 4 original sources each against 2.6 for the same window. At 7, the average consequence score sits above the same-window beat average of 6.4. We currently track 1 Startup story that mention CRISPR, all published on March 4, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering CRISPR. Shared-story counts are live from our verified record — not editorial picks.
Colossal Biosciences is advancing its mission to revive the woolly mammoth by 2028, sparking intense debate over the ethics of de-extinction. While the startup has secured over $225 million in venture capital, critics argue the project is a costly distraction from urgent conservation efforts for living species.
CRISPR is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
